title: Insomnia.
abstract: Insomnia is a common disorder, with individual and societal consequences. Advances have been made in the understanding of insomnia and its treatment options. However, cognitive behavioral therapy and Food and Drug Administration-approved pharmacologic therapies have limitations, the former primarily involving access and the latter involving potential side effects. Further research is needed to optimize management strategies.
authors.affiliation: Division of Sleep Medicine, Harvard Medical School, Sleep Health Centers, Brigham and Women's Hospital, 1505 Commonwealth Avenue, 5th Floor, Brighton, MA 02135, USA. Maryann_Deak@sleephealth.com
authors.forename: Maryann C
authors.initials: MC
authors.lastname: Deak
authors.forename: John W
authors.initials: JW
authors.lastname: Winkelman
mesh_terms: D000328:Adult; D015928:Cognitive Behavioral Therapy; D006801:Humans; D008297:Male; D018570:Risk Assessment; D007319:Sleep Initiation and Maintenance Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D016896:Treatment Outcome